Highlights CollPlant Biotechnologies Ltd.

Equities

CLGN

IL0004960188

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-17 pm EDT			5-day change	1st Jan Change
6.34 ^USD	-0.94%		-4.35%	-0.78%

Apr. 04	CollPlant Biotechnologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 02	CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CollPlant Biotechnologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 04	CI
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants	Jan. 02	CI
Earnings Flash (CLGN) COLLPLANT Posts Q3 Revenue $43,000	Nov. 29	MT
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
CollPlant Biotechnologies Issued US Patent for Photocurable Dermal Filler	Nov. 01	MT
Earnings Flash (CLGN) COLLPLANT Reports Q2 Revenue $10.2M	23-08-24	MT
Earnings Flash (CLGN) COLLPLANT Posts Q2 EPS $0.52	23-08-24	MT
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
CollPlant Biotechnologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-24	CI
Stratasys, CollPlant Biotechnologies to Bio-Fabricate Human Tissues, Organs	23-04-04	MT
Stratasys Ltd. and Collplant Biotechnologies Ltd. to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs	23-04-04	CI
CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives	23-01-04	CI
Collplant Enriches Portfolio of Rhcollagen-Based Bioinks with Launch of Collink.3Dtm 50L in Powder Form	23-01-03	CI
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-12-01	CI
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-12-01	CI
Earnings Flash (CLGN) COLLPLANT Posts Q3 Revenue $109,000	22-12-01	MT
Earnings Flash (CLGN) COLLPLANT Posts Q3 Loss $-0.34	22-12-01	MT
CollPlant, Tel Aviv University, Sheba Medical Center to Co-Develop Tissue Model for Drug Discovery to Treat Ulcerative Colitis	22-11-15	MT
Collplant Enters into A License and Research Agreement to Co-Develop A “Gut-On-A-Chip” Tissue Model for Drug Discovery and High Throughput Screening of Drugs	22-11-15	CI
CollPlant Biotechnologies Ltd., Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative Colitis	22-11-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights CollPlant Biotechnologies Ltd.

Equities

CLGN

IL0004960188

Highlights

Filters